《CELL,4月16日,Genomic epidemiology of SARS-CoV-2 in Guangdong Province, China》

  • 来源专题:COVID-19科研动态监测
  • 编译者: xuwenwhlib
  • 发布时间:2020-04-16
  • Genomic epidemiology of SARS-CoV-2 in Guangdong Province, China

    Jing Lu1,2,10, Louis du Plessis3,10, Zhe Liu1,2,10

    , Verity Hill4,10

    , Min Kang2

    , Huifang Lin1,2

    , Jiufeng

    Summary

    COVID-19 is caused by SARS-CoV-2 infection and was first reported in central China in December 2019. Extensive molecular surveillance in Guangdong, China’s most populous province, during early 2020 resulted in 1,388 reported RNA-positive cases from 1.6 million tests. In order to understand the molecular epidemiology and genetic diversity of SARS-CoV-2 in China we generated 53 genomes from infected individuals in Guangdong using a combination of metagenomic sequencing and tiling amplicon approaches. Combined epidemiological and phylogenetic analyses indicate multiple independent introductions to Guangdong, although phylogenetic clustering is uncertain due to low virus genetic variation early in the pandemic. Our results illustrate how the timing, size and duration

    of putative local transmission chains were constrained by national travel restrictions and by the province’s large-scale intensive surveillance and intervention measures. Despite these successes, COVID-19 surveillance in Guangdong is still required as the number of cases imported from other countries has increased.

  • 原文来源:https://www.cell.com/pb-assets/products/coronavirus/CELL_CELL-D-20-00921.pdf
相关报告
  • 《SSRN,2月4日,Epidemic Prediction of 2019-nCoV in Hubei Province and Comparison with SARS in Guangdong Province》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-02-06
    • Epidemic Prediction of 2019-nCoV in Hubei Province and Comparison with SARS in Guangdong Province 16 Pages Posted: 4 Feb 2020 Yuxiao Bai Xidian University Xun Nie Xidian University Chenxin Wen Xidian University Date Written: February 4, 2020 Abstract Since the first case of new coronavirus (2019-nCoV) pneumonia appeared in Wuhan, the virus has spread very rapidly in China on December 31st, with Hubei Province having the most severe epidemic situation. As of 24:00 on February 2nd, the cumulative number of confirmed cases in Hubei Province has reached up to 11,177. In this paper, we select the epidemic situation in Hubei Province as the research object to establish the SEIQDR model of infectious diseases. The parameters are determined from the existing data to predict the trend of the cumulative number of confirmed diagnoses, and the parameters are adjusted according to the prevention and control measures as well as possible changes. In comparison with Guangdong Province, where the SARS epidemic originated, it was concluded that the new coronavirus epidemic far exceeds the SARS epidemic in terms of infection rate and deaths. But thanks to the timely and effective prevention and control measures taken by the country, currently the epidemic is under control, and we predict the end of the epidemic is about 60 days earlier than the SARS virus. The total number of confirmed diagnoses in Hubei Province is 26,701 (ranges from 24,355 to 32,406), and the rapid growth period is expected to be from January 27th to February 10, and the epidemic will grow slowly after February 22nd. The growth is expected to stop on March 30th (ranges from March 26th to April 19th). *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.
  • 《4月15日_中国广东省SARS-CoV-2基因流行病学》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-04-17
    • 1.时间:2020年4月15日 2.机构或团队:广东省公共卫生研究所、广东省疾病预防控制中心、牛津大学、爱丁堡大学、深圳市疾病预防控制中心、广州市疾病预防控制中心、广东省第二人民医院、广州佛山市第一人民医院、伯明翰大学 3.事件概要: 4月15日,Cell期刊在线发表了来自广东省公共卫生研究所、广东省疾病预防控制中心等机构的研究团队的题为“Genomic epidemiology of SARS-CoV-2 in Guangdong Province, China”的文章。 该文章指出,到2020年初,在中国人口最多的广东省进行了广泛分子监测,从160万份检测中报告了1388例SARS-COV-2阳性病例。为了了解中国SARS-CoV-2的分子流行病学和遗传多样性,该研究结合了宏基因组测序和tiling扩增法,从广东省受感染的个体中获得了53个病毒基因组,流行病学和系统发育分析的结果表明,尽管大流行初期病毒基因的变异性低、系统发育聚类尚不确定,但多个独立的种群输入广东省。该文章指出,该研究揭示了国家出行限制以及广东省大规模密集监测和干预措施的约束对本地传输链的时间、规模和持续时间的影响。此外,该文章建议,随着从其他国家输入病例数量的增加,仍需要在广东进行COVID-19监测。 4.附件: 原文链接https://www.cell.com/pb-assets/products/coronavirus/CELL_CELL-D-20-00921.pdf